BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10691699)

  • 1. Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y(1) receptor antagonists.
    Kim YC; Gallo-Rodriguez C; Jang SY; Nandanan E; Adams M; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2000 Feb; 43(4):746-55. PubMed ID: 10691699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
    Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking.
    Kim HS; Barak D; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2001 Sep; 44(19):3092-108. PubMed ID: 11543678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
    Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
    J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
    Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
    Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.
    Camaioni E; Boyer JL; Mohanram A; Harden TK; Jacobson KA
    J Med Chem; 1998 Jan; 41(2):183-90. PubMed ID: 9457242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
    Houston D; Costanzi S; Jacobson KA; Harden TK
    Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.
    Cattaneo M; Lecchi A; Ohno M; Joshi BV; Besada P; Tchilibon S; Lombardi R; Bischofberger N; Harden TK; Jacobson KA
    Biochem Pharmacol; 2004 Nov; 68(10):1995-2002. PubMed ID: 15476670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
    Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
    Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
    Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier.
    de Castro S; Maruoka H; Hong K; Kilbey SM; Costanzi S; Hechler B; Brown GG; Gachet C; Harden TK; Jacobson KA
    Bioconjug Chem; 2010 Jul; 21(7):1190-205. PubMed ID: 20565071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.
    Raboisson P; Baurand A; Cazenave JP; Gachet C; Retat M; Spiess B; Bourguignon JJ
    J Med Chem; 2002 Feb; 45(4):962-72. PubMed ID: 11831909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
    Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
    J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
    Halbfinger E; Major DT; Ritzmann M; Ubl J; Reiser G; Boyer JL; Harden KT; Fischer B
    J Med Chem; 1999 Dec; 42(26):5325-37. PubMed ID: 10639276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors.
    Brown SG; King BF; Kim YC; Jang SY; Burnstock G; Jacobson KA
    Drug Dev Res; 2000 Apr; 49(4):253-259. PubMed ID: 22791931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
    Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
    J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
    Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
    Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL; Romero-Avila T; Schachter JB; Harden TK
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.